Idiopathic Pulmonary Fibrosis: A Composite Physiologic Index Derived from Disease Extent Observed by Computed Tomography
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In idiopathic pulmonary fibrosis, the quantitation of disease severity using pulmonary function tests is often confounded by emphysema. We have identified the composite physiologic index (CPI) most closely reflecting the morphologic extent of pulmonary fibrosis. Consecutive patients with a clinical/computed tomography (CT) diagnosis of idiopathic pulmonary fibrosis (n = 212) were divided into group I (n = 106) and group II (n = 106). The CPI was derived in group I (by fitting pulmonary function tests against disease extent on CT) and was tested in Group II. The formula for the CPI was as follows: extent of disease on CT = 91.0 − (0.65 × percent predicted diffusing capacity for carbon monoxide [DLCO]) − (0.53 × percent predicted FVC) + (0.34 × percent predicted FEV1). In group II, the CPI correlated more strongly with disease extent on CT (r2 = 0.51) than the individual pulmonary function test (DLCO the highest value, r2 = 0.38). A subanalysis demonstrated that the better fit of the CPI was ascribable to a correction of the confounding effects of emphysema. Mortality was predicted more accurately by the CPI than by a pulmonary function test in all clinical subgroups, including a separate cohort of 36 patients with histologically proven usual interstitial pneumonia (CPI, p < 0.0005; FVC, p = 0.002; PO2, p = 0.002). In conclusion, a new CPI, derived against CT and validated using split sample testing, is a more accurate prognostic determinant in usual interstitial pneumonia than an individual pulmonary function test.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, the Composite Physiologic Index (CPI) and the Gender-Age-Physiology (GAP) index have been most commonly applied for estimating the survival of patients with IPF [3–6].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
In the citing paper
“CPI quantifies pulmonary function impairment due to pulmonary fibrosis, which is then correlated with the extent of fibrosis in computed tomography while excluding emphysema [3].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [3]
Citations
Cites
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Austin, J. H., Müller, N. L., Friedman, P. J., Hansell, D. M., Naidich, D. P., Remy-Jardin, M., Webb, W. R., & Zerhouni, E. A. (1996) · Radiology · doi:10.1148/radiology.200.2.8685321 · Cited by 836
Self-citationHistopathologic Variability in Usual and Nonspecific Interstitial Pneumonias
FLAHERTY, K. R., TRAVIS, W. D., COLBY, T. V., TOEWS, G. B., KAZEROONI, E. A., GROSS, B. H., JAIN, A., STRAWDERMAN, R. L., FLINT, A., LYNCH, J. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103074 · Cited by 665
Self-citationIdeal Alveolar Air and the Analysis of Ventilation-Perfusion Relationships in the Lungs
Riley, R. L., & Cournand, A. (1949) · Journal of Applied Physiology · doi:10.1152/jappl.1949.1.12.825 · Cited by 563
Travis, W. D., Matsui, K., Moss, J., & Ferrans, V. J. (2000) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200001000-00003 · Cited by 530
NICHOLSON, A. G., COLBY, T. V., DUBOIS, R. M., HANSELL, D. M., & WELLS, A. U. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.6.2003049 · Cited by 489
Self-citationIdiopathic Pulmonary Fibrosis: Predicting Response to Therapy and Survival
GAY, S. E., KAZEROONI, E. A., TOEWS, G. B., LYNCH, J. P., GROSS, B. H., CASCADE, P. N., SPIZARNY, D. L., FLINT, A., ANTHONY SCHORK, M., WHYTE, R. I., et al. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9703022 · Cited by 406
Determinants of survival in idiopathic pulmonary fibrosis.
Schwartz, D. A., Helmers, R. A., Galvin, J. R., Van Fossen, D. S., Frees, K. L., Dayton, C. S., Burmeister, L. F., & Hunninghake, G. W. (1994) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.149.2.8306044 · Cited by 340
Research works printed but not linked: 7
- 1995, Am J Respir Crit Care Med, 151, 1180
- 1997, Arthritis Rheum, 40, 1229
- 1983, Clin Respir Physiol, 19, 1
- 1994, Am J Respir Crit Care Med, 149, 450, 10.1164/ajrccm.149.2.8306044 · DOI · Paper page
- 1983, Am Rev Respir Diagn, 2, 43
- 1976, Chest, 69, 263
- 1995, Am J Respir Crit Care Med, 151, 1180
Cited by
Items 201–300 of 705
Choi, S. H., Lee, H. Y., Lee, K. S., Chung, M. P., Kwon, O. J., Han, J., Kim, N., & Seo, J. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107476 · Cited by 53
“The composite physiologic index (CPI) was developed to improve upon previous prognostic measures in IPF by adjusting for emphysema and incorporating multiple components of pulmonary function, such as forced expiratory volume in 1 second (FEV1), FVC and DLCO [1].”
BackgroundMethodInfluentialAdvanced pulmonary sarcoidosis
Valeyre, D., Nunès, H., & Bernaudin, J. (2014) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0000000000000075 · Cited by 54
Automated computer-based CT stratification as a predictor of outcome in hypersensitivity pneumonitis
Jacob, J., Bartholmai, B. J., Rajagopalan, S., Karwoski, R. A., Mak, S., Mok, W. Y., Casa, G. D., Sugino, K., Walsh, S. L. F., Wells, A. U., et al. (2017) · European Radiology · doi:10.1007/s00330-016-4697-4 · Cited by 54
“Significant functional differences across all groups were identified with FVC, TLC and CPI, with differences in at least two groups identified with FEV1 and DLco (Table 3).”
BackgroundSelf-citationGannon, W. D., Lederer, D. J., Biscotti, M., Javaid, A., Patel, N. M., Brodie, D., Bacchetta, M. D., & Baldwin, M. R. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.01.006 · Cited by 54
Postoperative Acute Exacerbation of IPF after Lung Resection for Primary Lung Cancer
Watanabe, A., Kawaharada, N., & Higami, T. (2011) · Pulmonary Medicine · doi:10.1155/2011/960316 · Cited by 52
“with %VC < 80% [16, 17], low DLCO [16], and %TLC < 95% [29].”
BackgroundA new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Collard, H. R., Bradford, W. Z., Cottin, V., Flaherty, K. R., King, T. E., Koch, G. G., Kolb, M. R. J., Martínez, F. J., Montgomery, B., Raghu, G., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00200614 · Cited by 55
Self-citationKinder, B. W., Shariat, C., Collard, H. R., Koth, L. L., Wolters, P. J., Golden, J. A., Panos, R. J., & King, T. E. (2010) · Lung · doi:10.1007/s00408-009-9226-7 · Cited by 53
“Other clinical variables included in the initial regression analyses were age, gender, smoking status, baseline percent predicted FVC, and baseline percent predicted DLCO, treatment, composite physiologic index (CPI) [18] and duration between PFT studies.”
BackgroundPreoperative Pulmonary Risk Assessment
Sameed, M., Choi, H., Aurón, M., & Mireles‐Cabodevila, E. (2021) · Respiratory Care · doi:10.4187/respcare.09154 · Cited by 57
“80,81 The utility of this index remains to be validated for general surgery.”
CT in Idiopathic Pulmonary Fibrosis: Diagnosis and Beyond
Gruden, J. F. (2016) · American Journal of Roentgenology · doi:10.2214/ajr.15.15674 · Cited by 53
“This led to the development of other more complex methods for monitoring patients with IPF, although neither achieved widespread clinical application [48, 49].”
BackgroundMethodResultEvaluation and management of Idiopathic Pulmonary Fibrosis
Kishaba, T. (2019) · Respiratory Investigation · doi:10.1016/j.resinv.2019.02.003 · Cited by 55
Lee, S. H., Park, J. S., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., Park, C. S., Park, S. W., Jeong, S. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23073-3 · Cited by 50
Combined pulmonary fibrosis and emphysema: The many aspects of a cohabitation contract
Papaioannou, A. Ι., Κostikas, Κ., Manali, E. D., Papadaki, G. F., Roussou, A., Kolilekas, L., Borie, R., Bouros, D. E., & Papiris, S. A. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.05.005 · Cited by 50
Desai, S. R., Hansell, D. M., Walker, A. E., MacDonald, S. L. S., Chabat, F., & Wells, A. U. (2006) · European Radiology · doi:10.1007/s00330-006-0369-0 · Cited by 50
“One of the principal benefits of the composite index in IPF was that, as in the current study, the score was derived from routinely collected functional measures.”
BackgroundResultInfluentialSelf-citationMajewski, S., Szewczyk, K., Żal, A., Białas, A. J., Miłkowska-Dymanowska, J., & Piotrowski, W. J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173864 · Cited by 53
“CPI was developed as a tool to reflect the morphologic extent of fibrosis in patients with IPF [24].”
MethodSverzellati, N., Calabrò, E., Chetta, A. A., Concari, G., Larici, A. R., Mereu, M. L., Cobelli, R., Filippo, M. D., & Zompatori, M. (2007) · La radiologia medica · doi:10.1007/s11547-007-0213-x · Cited by 48
Increased epithelial permeability in pulmonary fibrosis in relation to disease progression
Goh, N. S. L., Desai, S. R., Anagnostopoulos, C., Hansell, D. M., Hoyles, R. K., Sato, H., Denton, C. P., Black, C. M., du Bois, R. M., & Wells, A. U. (2010) · European Respiratory Journal · doi:10.1183/09031936.00010910 · Cited by 50
Self-citationConti, C., Montero, Á., Borg, E., Osadolor, T., Viola, P., Lauretis, A. D., Stock, C. J. W., Bonifazi, M., Bonini, M., Caramori, G., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201507-1322le · Cited by 48
Self-citationHighlights of HRCT imaging in IPF
Sverzellati, N. (2013) · Respiratory Research · doi:10.1186/1465-9921-14-s1-s3 · Cited by 48
“Furthermore, HRCT can quantify the extent of lung abnormalities and be used to make up composite indexes that better estimate disease severity and prognosis [1-3].”
BackgroundClinical review: Idiopathic pulmonary fibrosis—Past, present and future
Dempsey, O. J. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.08.017 · Cited by 60
Combined pulmonary fibrosis and emphysema: How does cohabitation affect respiratory functions?
Çiftçi, F., Gülpınar, B., Atasoy, Ç., Kayacan, O., & Saryal, S. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.03.005 · Cited by 46
MR elastography of the lung with hyperpolarized 3He
McGee, K. P., Hubmayr, R. D., & Ehman, R. L. (2007) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21465 · Cited by 46
“Whereas computed tomography (CT) is an excellent method of assessment of disease extent, particularly in interstitial lung diseases that produce fibrotic-induced morphological changes to the lung, attempts to derive physiological measures from CT including CT histogram derived parameters (6) or composite physiologic i…”
BackgroundNurmi, H., Purokivi, M., Kärkkäinen, M. S., Kettunen, H.-P., Selander, T. A., & Kaarteenaho, R. L. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0358-2 · Cited by 48
Lung function outcomes in the INPULSIS® trials of nintedanib in idiopathic pulmonary fibrosis
Brown, K. K., Flaherty, K. R., Cottin, V., Raghu, G., Inoue, Y., Azuma, A., Huggins, J. T., Richeldi, L., Stowasser, S., Stansen, W., et al. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2018.11.012 · Cited by 44
Self-citationMyositis-Related Interstitial Lung Diseases: Diagnostic Features, Treatment, and Complications
Shappley, C., Paik, J. J., & Saketkoo, L. A. (2019) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-018-0110-6 · Cited by 46
Kreuter, M., Kögler, H., Trampisch, M., Geier, S., & Richeldi, L. (2019) · Respiratory Research · doi:10.1186/s12931-019-1037-7 · Cited by 49
Mura, M., Ferretti, A., Ferro, O., Zompatori, M., Cavalli, A., Schiavina, M., & Fabbri, M. (2005) · Respiration · doi:10.1159/000089656 · Cited by 46
Fujii, M., Shirai, T., Mori, K., Mikamo, M., Shishido, Y., Akita, T., Morita, S., Asada, K., & Suda, T. (2014) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2014.12.009 · Cited by 45
Cheng, J. Z., Wilcox, P., Glaspole, I., Corte, T. J., Murphy, D. T., Hague, C. J., & Ryerson, C. J. (2017) · Respirology · doi:10.1111/resp.13084 · Cited by 46
Lee, S. H., Yeo, Y., Kim, T., Lee, H. L., Lee, J. H., Park, Y. B., Park, J. S., Kim, Y. H., Song, J. W., Jhun, B. W., et al. (2019) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2018.0091 · Cited by 50
Ruan, P., Todd, J. L., Zhao, H., Liu, Y., Vinisko, R., Söllner, J. F., Schmid, R., Kaner, R. J., Luckhardt, T., Neely, M. L., et al. (2023) · Respiratory Research · doi:10.1186/s12931-023-02435-0 · Cited by 43
Kishaba, T., Nagano, H., Nei, Y., & Yamashiro, S. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.12.49 · Cited by 47
“Mean CPI and GAP scores were approximately 50 and 4, respectively.”
BackgroundMethodInfluentialSeverity and features of frailty in systemic sclerosis-associated interstitial lung disease
Guler, S. A., Kwan, J. M., Winstone, T. A., Milne, K. M., Dunne, J. V., Wilcox, P., & Ryerson, C. J. (2017) · Respiratory Medicine · doi:10.1016/j.rmed.2017.05.012 · Cited by 45
Disease Severity and Quality of Life in Patients With Idiopathic Pulmonary Fibrosis
O'Brien, E. C., Hellkamp, A. S., Neely, M. L., Swaminathan, A. C., Bender, S. D., Snyder, L. D., Culver, D. A., Conoscenti, C., Todd, J. L., Palmer, S. M., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2019.11.042 · Cited by 43
Smoking and Pulmonary Fibrosis: Novel Insights
Samara, K. D., Margaritopoulos, G. A., Wells, A. U., Siafakas, N. M., & Antoniou, K. M. (2011) · Pulmonary Medicine · doi:10.1155/2011/461439 · Cited by 43
“Moreover, in severe IPF cases, emphysematous regions can be mixed with honeycomb changes—thus the authors used the composite physiologic index (CPI) [11] as a severity variable able to take smoking-related damage independently into account.”
BackgroundSelf-citationThe Role of Cardiopulmonary Exercise Test in IPF Prognosis
Triantafillidou, C., Manali, E. D., Lyberopoulos, P., Kolilekas, L. F., Kagouridis, K., Gyftopoulos, S., Vougas, K. N., Kotanidou, A. N., Alchanatis, M., Karakatsani, A., et al. (2013) · Pulmonary Medicine · doi:10.1155/2013/514817 · Cited by 44
“In IPF, most composite indices that have been identified by now usually derive from the extent of fibrosis on HRCT, pulmonary function test variables, and clinical parameters such as age and gender, thus precluding the prognostic strength of exercise data [12, 31, 32].”
BackgroundOhkubo, H., Nakagawa, H., & Niimi, A. (2017) · Respiratory Investigation · doi:10.1016/j.resinv.2017.10.003 · Cited by 44
Combined Pulmonary Fibrosis and Emphysema
Nemoto, M., Koo, C. W., Scanlon, P. D., & Ryu, J. H. (2023) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2023.05.002 · Cited by 43
Sharp, C., Adamali, H. I., & Millar, A. B. (2017) · ERJ Open Research · doi:10.1183/23120541.00096-2016 · Cited by 41
Lung transplantation in IIP : A review
Brown, A. W., Kaya, H., & Nathan, S. D. (2015) · Respirology · doi:10.1111/resp.12691 · Cited by 44
Outcome Measures for Clinical Trials in Interstitial Lung Diseases
Lammi, M. R., Baughman, R. P., Birring, S. S., Russell, A., Ryu, J. H., Scholand, M. B., Distler, O., LeSage, D., Sarver, C., Antoniou, K. M., et al. (2015) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x11666150619183527 · Cited by 43
“[69,70,71,78,84,87,88,94]; but statistically loses significance when adjusted for lung function suggesting need for either finer techniques for fibrosis quantification or continued efforts in the development of an index comprised of multiple variables (lung, function, HRCT, demographics, co-morbidities) [91–94].”
BackgroundSelf-citationYamamoto, Y., Yano, Y., Kuge, T., Okabe, F., Ishijima, M., Uenami, T., Kanazu, M., Akazawa, Y., Yamaguchi, T., & Mori, M. (2020) · Thoracic Cancer · doi:10.1111/1759-7714.13675 · Cited by 42
Nicholson, A. G. (2008) · Springer eBooks · doi:10.1007/978-0-387-68792-6_19 · Cited by 41
Self-citationNakagawa, H., Nagatani, Y., Takahashi, M., Ogawa, E., Tho, N. V., Ryujin, Y., Nagao, T., & Nakano, Y. (2015) · European Journal of Radiology · doi:10.1016/j.ejrad.2015.11.011 · Cited by 40
“The CPI, which is calculated rom values of FEV1, FVC and DLCO, is a more accurate prognostic eterminant than any individual parameters of PFTs [8].”
BackgroundMethodInfluentialApproach to the Diagnosis of Interstitial Lung Disease
Behr, J. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.12.002 · Cited by 40
The six-minute walk test in patients with pulmonary sarcoidosis
Alhamad, E. H. (2009) · Annals of Thoracic Medicine · doi:10.4103/1817-1737.49414 · Cited by 42
“More complex scoring methods have been utilized for patients with idiopathic pulmonary Þ brosis and present useful tools in assessing disease severity and predicting survival.[42-44] CRP signiÞ cantly correlated with walking distance and potentially appears as an effective prognostic tool in patients diagnosed clinica…”
MethodLiu, B., Jiang, T., Hu, X., Liu, Z., Zhao, L., Liu, H., Liu, Z., & Ma, L. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9565 · Cited by 44
Imaging of Pulmonary Sarcoidosis—A Review
Bailey, G., Wells, A. U., & Desai, S. R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030822 · Cited by 41
Self-citationKhadawardi, H. A., & Mura, M. (2016) · Respirology · doi:10.1111/resp.12945 · Cited by 40
Chandel, A., Pastré, J., Valéry, S., King, C. S., & Nathan, S. D. (2022) · Thorax · doi:10.1136/thoraxjnl-2021-218440 · Cited by 39
Clinical features and outcomes of 210 patients with idiopathic pulmonary fibrosis
Cai, M., Zhu, M., Ban, C., Su, J., Ye, Q., Liu, Y., Zhao, W., Wang, C., & Dai, H. (2014) · Chinese Medical Journal · doi:10.3760/cma.j.issn.0366-6999.20132528 · Cited by 42
Tasaka, S., Mizoguchi, K., Funatsu, Y., Namkoong, H., Yamasawa, W., Ishii, M., Hasegawa, N., & Betsuyaku, T. (2012) · Respirology · doi:10.1111/j.1440-1843.2012.02182.x · Cited by 41
Clinical characteristics of idiopathic pulmonary fibrosis patients according to their smoking status
Kishaba, T., Nagano, H., Nei, Y., & Yamashiro, S. (2016) · Journal of Thoracic Disease · doi:10.21037/jtd.2016.03.89 · Cited by 37
“We also calculated the composite physiologic index (CPI) according to the following formula (18): CPI =91−(0.”
MethodThe role of precision medicine in interstitial lung disease
Maher, T. M., Nambiar, A. M., & Wells, A. U. (2022) · European Respiratory Journal · doi:10.1183/13993003.02146-2021 · Cited by 38
“…parameters (percentage predicted FVC and percentage predicted D LCO ) to help predict ILD prognosis, while the Composite Physiologic Index is a prognostic tool that reconciles the morphological extent of pulmonary fibrosis with lung function parameters, including FEV 1 , FVC and D LCO [21, 22].”
Self-citationTherapeutic effects of nintedanib are not influenced by emphysema in the INPULSIS trials
Cottin, V., Azuma, A., Raghu, G., Stansen, W., Stowasser, S., Schlenker‐Herceg, R., & Kolb, M. R. J. (2019) · European Respiratory Journal · doi:10.1183/13993003.01655-2018 · Cited by 40
Alveolar concentration of nitric oxide as a prognostic biomarker in idiopathic pulmonary fibrosis
Cameli, P., Bergantini, L., Salvini, M., Refini, R. M., Pieroni, M., Bargagli, E., & Sestini, P. (2019) · Nitric Oxide · doi:10.1016/j.niox.2019.05.001 · Cited by 39
Copley, S. J., Lee, G., Hansell, D. M., Sivakumaran, P., Rubens, M. B., Taylor, A. J. N., Rudd, R., Musk, A. W., & Wells, A. U. (2007) · Radiology · doi:10.1148/radiol.2421051167 · Cited by 38
Self-citationRubio‐Rivas, M., & Corbella, X. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.024 · Cited by 38
Sangani, R. G., Ghio, A. J., Culp, S., Patel, Z., & Sharma, S. (2021) · International Journal of COPD · doi:10.2147/copd.s307192 · Cited by 37
“Given the inherent limitation of FVC in CPFE, a composite physiologic index (CPI) has similarly been developed to predict mortality in IPF patients with or without emphysema.(54) Longitudinal analysis of an IPF registry has shown an association of disease severity, based on physiological impairment and phenotypic clus…”
MethodLynch, J. P., Fishbein, M. C., Saggar, R., Zisman, D. A., & Belperio, J. A. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.3.377 · Cited by 37
Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study
Nolan, C. M., Maddocks, M. M., Maher, T. M., BANYA, W. A. S., Patel, S., Barker, R. E., Jones, S. E., George, P. M., Cullinan, P., & Man, W. D. (2018) · European Respiratory Journal · doi:10.1183/13993003.01186-2018 · Cited by 37
Sverzellati, N., Silva, M., Seletti, V., Galeone, C., Palmucci, S., Piciucchi, S., Vancheri, C., Poletti, V. E., Tomassetti, S., Karwoski, R. A., et al. (2020) · European Radiology · doi:10.1007/s00330-019-06619-5 · Cited by 38
Onishchenko, D., Marlowe, R. J., Ngufor, C. G., Faust, L. J., LIMPER, A. H., Hunninghake, G. M., Martínez, F. J., & Chattopadhyay, I. (2022) · Nature Medicine · doi:10.1038/s41591-022-02010-y · Cited by 40
Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis
van der Plas, M. N., van Kan, C., Blumenthal, J., Jansen, H. M., Wells, A. U., & Bresser, P. (2013) · Respirology · doi:10.1111/resp.12206 · Cited by 38
Self-citationMartin, M. D., Chung, J. H., & Kanne, J. P. (2016) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000204 · Cited by 38
FAM13A polymorphism as a prognostic factor in patients with idiopathic pulmonary fibrosis
Hirano, C., Ohshimo, S., Horimasu, Y., Iwamoto, H., Fujitaka, K., Hamada, H., Hattori, N., Shime, N., Bonella, F., Guzman, J., et al. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.12.007 · Cited by 36
Breath biomarkers in idiopathic pulmonary fibrosis: a systematic review
Hayton, C., Terrington, D. L., Wilson, A. M., Chaudhuri, N., Leonard, C. T., & Fowler, S. J. (2019) · Respiratory Research · doi:10.1186/s12931-019-0971-8 · Cited by 38
“Composite scoring systems such as the Composite-Physiologic Index (CPI) and Gender Age Physiology (GAP) index [19, 20], which incorporate demographic and physiological data, may represent more accurate prognostic models.”
BackgroundStock, C. J. W., Bray, W. G., Kouranos, V., Jacob, J., Kokosi, M. A., George, P. M., Chua, F., Wells, A. U., Sestini, P., & Renzoni, E. A. (2023) · Respirology · doi:10.1111/resp.14609 · Cited by 37
“12 Survival analysis was performed using proportional Cox regression.”
MethodSelf-citationMori, S. (2015) · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine · doi:10.4137/ccrpm.s23288 · Cited by 39
Aihara, K., Handa, T., Oga, T., Watanabe, K., Tanizawa, K., Ikezoe, K., Taguchi, Y., Sato, H., Chin, K., Nagai, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066017 · Cited by 35
“FVC, DLCO, CPI and desaturation during 6MWT predicted mortality in our cohort of patients with IPF, which is consistent with previous studies [11,17,19,20].”
BackgroundMethodResultSelf-citationPhenotypic characteristics associated with slow gait speed in idiopathic pulmonary fibrosis
Nolan, C. M., Maddocks, M. M., Maher, T. M., Canavan, J. L., Jones, S. E., Barker, R. E., Patel, S., Jacob, J., Cullinan, P., & Man, W. D. (2017) · Respirology · doi:10.1111/resp.13213 · Cited by 38
Las pruebas funcionales respiratorias en las decisiones clínicas
Puente‐Maestu, L., & de Pedro, J. G. (2012) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2011.12.012 · Cited by 47
Grading the Severity of Obstruction in Mixed Obstructive-Restrictive Lung Disease
Gardner, Z. S., Ruppel, G. L., & Kaminsky, D. A. (2011) · CHEST Journal · doi:10.1378/chest.10-2860 · Cited by 35
Urteaga, M. B., Ruz, J. R., & González, M. S. (2022) · Radiología (English Edition) · doi:10.1016/j.rxeng.2022.10.009 · Cited by 40
Circulating metabolic profile in idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
Summer, R. S., Todd, J. L., Neely, M. L., Lobo, L. J., Namen, A. M., Newby, L. K., Shafazand, S., Suliman, S. A., Heßlinger, C., Keller, S., et al. (2024) · Respiratory Research · doi:10.1186/s12931-023-02644-7 · Cited by 35
“…models were used to determine the associations between circulating metabolites and three clinical measures of disease severity at enrollment: forced vital capacity (FVC) % predicted, diffusion capacity of the lung for carbon monoxide (DLco) % predicted, and composite physiologic index (CPI) [31].”
MethodBrown, A. W., Shlobin, O. A., Weir, N. A., Albano, M. C., Ahmad, S., Smith, M. A., Leslie, K. O., & Nathan, S. D. (2012) · CHEST Journal · doi:10.1378/chest.12-0298 · Cited by 36
Disease severity staging system for idiopathic pulmonary fibrosis in Japan
Kondoh, Y., Taniguchi, H., Kataoka, K., Furukawa, T., Ando, M., Murotani, K., Mishima, M., Inoue, Y., Ogura, T., Bando, M., et al. (2017) · Respirology · doi:10.1111/resp.13138 · Cited by 38
Quantitative CT‐derived vessel metrics in idiopathic pulmonary fibrosis: A structure–function study
Jacob, J., Pienn, M., Payer, C., Urschler, M., Kokosi, M. A., Devaraj, A., Wells, A. U., & Olschewski, H. (2019) · Respirology · doi:10.1111/resp.13485 · Cited by 33
Self-citationMikolasch, T., George, P. M., Sahota, J., Nancarrow, T., Barratt, S. L., Woodhead, F., Kouranos, V., Cope, V. S. A., Creamer, A. W., Fidan, S., et al. (2022) · EClinicalMedicine · doi:10.1016/j.eclinm.2022.101758 · Cited by 33
Self-citationDo High-Resolution CT Findings of Usual Interstitial Pneumonitis Obviate Lung Biopsy?
Diette, G. B., Scatarige, J. C., Haponik, E. F., Merriman, B., & Fishman, E. K. (2005) · Respiration · doi:10.1159/000084043 · Cited by 40
Federal clinical guidelines on diagnosis and treatment of idiopathic pulmonary fibrosis
Avdeev, S. N., Айсанов, З. Р., Belevskiy, А. S., Ilkovich, M. M., Коган, Е. А., Мержоева, З. М., Petrov, D., Samsonova, M. V., Terpigorev, S. A., Трушенко, Н. В., et al. (2022) · PULMONOLOGIYA · doi:10.18093/0869-0189-2022-32-3-473-495 · Cited by 32
Is personalised medicine the key to heterogeneity in idiopathic pulmonary fibrosis?
Clarke, D. L., Murray, L. A., Crestani, B., & Sleeman, M. A. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.09.010 · Cited by 33
Detection and classification of systemic sclerosis-related interstitial lung disease: a review
DeMizio, D. J., & Bernstein, E. J. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000660 · Cited by 32
Gangemi, A. J., Myers, C. N., Zheng, M., Brown, J., Butler-Lebair, M., CORDOVA, F. C., Marchetti, N. T., Criner, G. J., Gupta, R., & Mamary, A. J. (2019) · Respiratory Medicine · doi:10.1016/j.rmed.2019.09.001 · Cited by 31
Piotrowski, W. J., Bestry, I., Białas, A. J., Boros, P. W., Grzanka, P., Jassem, E., Jastrzębski, D., Klimczak, D., Langfort, R., Lewandowska, K. B., et al. (2020) · Advances in respiratory medicine · doi:10.5603/arm.2020.0081 · Cited by 32
Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
Meier, C. F., Freiburghaus, K., Bovet, C., Gote-Schniering, J., Allanore, Y., Distler, O., Nakas, C. T., & Maurer, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-78951-6 · Cited by 30
Risk Factors of Silicosis Progression: A Retrospective Cohort Study in China
Quan, H., Wu, W., Yang, G., Wu, Y., Yang, W., Min, C. Y., Shi, J., Qin, L., Huang, J., Wang, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.832052 · Cited by 32
“CPI is commonly used to evaluate the severity of idiopathic pulmonary fibrosis (IPF) disease (20).”
BackgroundMethodJee, A. S., Stewart, I. D., Youssef, P. P., Adelstein, S., Lai, D., Hua, S., Stevens, W., Proudman, S., Ngian, G., Glaspole, I., et al. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42491 · Cited by 31
“ILDs, from clinical and physiologic variables (15).”
Mitchell, P. D., Das, J. P., Murphy, D. J., Keane, M. P., Donnelly, S. C., Dodd, J. D., & Butler, M. W. (2014) · Respiratory Care · doi:10.4187/respcare.03389 · Cited by 31
Lung Function Tests in Clinical Decision-Making
Puente‐Maestu, L., & de Pedro, J. G. (2012) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2011.12.007 · Cited by 36
Jacob, J., Bartholmai, B. J., Brun, A., Egashira, R., Rajagopalan, S., Karwoski, R. A., Kouranos, V., Kokosi, M. A., Hansell, D. M., & Wells, A. U. (2017) · Respirology · doi:10.1111/resp.13122 · Cited by 31
Self-citationCalandriello, L., & Walsh, S. L. F. (2017) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0037-1603765 · Cited by 31
Decramer, M., Janssens, W., Derom, E., Joos, G., Ninane, V., Deman, R., Renterghem, D. V., Liistro, G., & Bogaerts, K. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70184-x · Cited by 29
Ariani, A., Silva, M., Bravi, E., Saracco, M., Parisi, S., Gennaro, F. D., Lumetti, F., Idolazzi, L., Seletti, V., Caramaschi, P., et al. (2015) · Modern Rheumatology · doi:10.3109/14397595.2015.1016200 · Cited by 29
Richeldi, L., Collard, H. R., du Bois, R. M., Jenkins, G. R., Kolb, M. R. J., Maher, T. M., Raghu, G., Vancheri, C., & Laurent, G. J. (2013) · European Respiratory Journal · doi:10.1183/09031936.00038613 · Cited by 29
Kouranos, V., Jacob, J., & Wells, A. U. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.08.012 · Cited by 36
Self-citationExercise training in idiopathic pulmonary fibrosis
Vainshelboim, B., Fox, B. D., de Oliveira, J. J. F., & Kramer, M. R. (2015) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2016.1121104 · Cited by 30
Assessing Mortality Models in Systemic Sclerosis-Related Interstitial Lung Disease
Mango, R. L., Matteson, E. L., Crowson, C. S., Ryu, J. H., & Makol, A. (2018) · Lung · doi:10.1007/s00408-018-0126-6 · Cited by 28
Machahua, C., Guler, S. A., Horn, M. P., Planas‐Cerezales, L., Montes‐Worboys, A., Geiser, T., Molina‐Molina, M., & Funke-Chambour, M. (2021) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2020-000827 · Cited by 29
Ueno, F., Kitaguchi, Y., Shiina, T., Asaka, S., Miura, K., Yasuo, M., Wada, Y., Yoshizawa, A., & Hanaoka, M. (2017) · Respiration · doi:10.1159/000477587 · Cited by 27
Metadata
- Authors
- Wells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M.
- Affiliations
- Mayo Clinic (US)
- Department of Radiology and Department of Physiology Royal Brompton Hospital, Interstitial Lung Disease Unit; Department of Radiology, King's College Hospital, London, United Kingdom; and Department of Pathology, Mayo Clinic, Scottsdale, Arizona
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-01
- Volume
- 167
- Issue
- 7
- Pages
- 962-969
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W3022958008
- Cited by
- 686
- References
- 32
- Citations by year
- 2026: 18 · 2025: 31 · 2024: 28 · 2023: 39 · 2022: 37 · 2021: 48 · 2020: 42 · 2019: 40 · 2018: 40 · 2017: 52 · 2016: 47 · 2015: 42 · 2014: 27 · 2013: 38 · 2012: 22
- FWCI
- 12.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, usual interstitial pneumonia, composite physiologic index, pulmonary function tests, diffusing capacity for carbon monoxide, mortality prediction, prognostic score
- MeSH terms
- Aged, Biopsy, Carbon Monoxide, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Lung, Male, Middle Aged, Monitoring, Physiologic, Predictive Value of Tests, Prognosis, Pulmonary Diffusing Capacity, Pulmonary Emphysema, Pulmonary Fibrosis, Statistics as Topic, Tomography, X-Ray Computed, Total Lung Capacity, Vital Capacity, Survival Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.